---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Inotuzumab Ozogamicin - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/inotuzumabozogamicin
version: v1
---

# Inotuzumab Ozogamicin - NCI

# Inotuzumab Ozogamicin

Placeholder slot

(ih-noh-TOO-zoo-mab OH-zoh-ga-MIH-sin)

This page contains brief information about inotuzumab ozogamicin and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Besponsa

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc7014b1-c775-411d-b374-8113248b4077&audience=consumer)

## Use in Cancer

Inotuzumab ozogamicin
is approved to treat adults and children aged 1 year and older with:

- **[B-cell acute lymphoblastic leukemia](/Common/PopUps/popDefinition.aspx?id=543504&version=Patient&language=English)** (ALL) that is CD22 positive and has come back or did not respond to treatment.

Inotuzumab ozogamicin
is also being studied in the treatment of other types of
cancer.

## More About Inotuzumab Ozogamicin

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/352004) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Inotuzumab Ozogamicin](https://medlineplus.gov/druginfo/meds/a617041.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Monoclonal Antibodies](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Inotuzumab Ozogamicin](https://www.cancer.gov/research/participate/clinical-trials/intervention/C71542) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
